Agreed standards will drive all industry players towards the same goal: better bioprocessing. And efforts from BPOG, among others, are leading the way.

Processing has evolved thanks to single-use technologies and the next big transformation is on the horizon: continuous bioprocessing.

Biopharma manufacturers may choose to use stainless steel or single-use equipment. The decision will depend on the product portfolio and the company’s own needs and resources.

Why new biopharma processing technology and automated processing is key to driving down costs and boosting facility efficiency.

A helpful guide through all steps of a bioprocess, starting from the preparation of the inoculum to the preparation and operation of the vessels and bioprocess systems, the bioprocess run itself, and the analysis of samples.

As the industry is looking to increase speed to market, reduce manufacturing resources and increase product safety, there has been a push to implement single-use technologies. Combining both SPTFF and single-use technology can be a powerful tool for the efficient manufacture of biologics.

This webinar discusses several scaling approaches, such as constant tip speed, kLa, and power number-based scale-up.

This webcast reviews a research example for process development with the human tumor cell line H157, cultivated in stirred-tank mini bioreactors as 3D cell aggregates.

See applications of MVA and DoE in bioprocess development and how these powerful tools can be integrated in this live webcast.

This webinar discusses a research project focused on determining if the three primary methods of production for a typical biosimilar (batch, fed-batch, and perfusion) may be simply and easily executed using a single, benchtop bioprocess control system.